Network Pharmacology and Molecular Docking Based Prediction of Mechanism of Pharmacological Attributes of Glutinol

Glutinol, a triterpenoid compound, has no documented systematic investigation into its mechanism. Hence, we used network pharmacology to investigate glutinol’s mechanism. The chemical formula of glutinol was searched in the PubChem database for our investigation. The BindingDB Database was utilized...

Full description

Saved in:
Bibliographic Details
Published in:Processes 2022-08, Vol.10 (8), p.1492
Main Authors: Alzarea, Sami I, Qasim, Sumera, Uttra, Ambreen Malik, Khan, Yusra Habib, Aljoufi, Fakhria A, Ahmed, Shaimaa Rashad, Alanazi, Madhawi, Malhi, Tauqeer Hussain
Format: Article
Language:English
Subjects:
Bioinformatics
Biological activity
Cancer
Carcinogenesis
Carcinogens
Diabetes
Diabetes mellitus
Drug development
Encyclopedias
Energy
Genes
Genomes
Inflammation
Inflammatory response
Insulin resistance
Ligands
Molecular docking
Network analysis
Pharmacology
Proteins
Software
Steroids
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glutinol, a triterpenoid compound, has no documented systematic investigation into its mechanism. Hence, we used network pharmacology to investigate glutinol’s mechanism. The chemical formula of glutinol was searched in the PubChem database for our investigation. The BindingDB Database was utilized to discover probable glutinol target genes after ADMET analysis with the pkCSM software. DAVID tools were also used to perform Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of target genes. We also uploaded the targets to the STRING database to obtain the protein interaction network at the same time. Then, we performed some molecular docking using glutinol and targets. Finally, we used Cytoscape to visualize and evaluate a protein–protein interaction network and a drug-target-pathway network. Glutinol has good biological activity and drug utilization, according to our findings. A total of 32 target genes were discovered. Bioinformatics and network analysis were used, allowing the discovery that these target genes are linked to carcinogenesis, diabetes, inflammatory response, and other biological processes. These findings showed that glutinol can operate on a wide range of proteins and pathways to establish a pharmacological network that can be useful in drug development and use.
ISSN:2227-9717
2227-9717
DOI:10.3390/pr10081492